Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Netflix, Biogen And Other Big Gainers From Wednesday

Published 29/09/2022, 08:45
Updated 29/09/2022, 09:40
© Reuters Netflix, Biogen And Other Big Gainers From Wednesday

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

  • Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares rose 103.8% to close at $9.58 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
  • Prothena Corporation plc (NASDAQ: PRTA) shares jumped 87.5% to close at $58.00 on Wednesday after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative diseases, like Alzheimer’s.
  • Biogen Inc. (NASDAQ: NASDAQ:BIIB) shares rose 39.9% to close at $276.61. Biogen and Eisai Co. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.
  • Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) gained 20.1% to close at $3.47.
  • Denali Therapeutics Inc. (NASDAQ: DNLI) gained 17.7% to close at $32.12.
  • Workiva Inc. (NYSE: WK) jumped 17.6% to close at $76.15. Workiva is said to draw Thoma Bravo, TPG interest, Bloomberg reported.
  • Coeur Mining, Inc. (NYSE: CDE) jumped 15.2% to close at $3.26.
  • Peabody Energy Corporation (NYSE: BTU) gained 11.6% to close at $24.85.
  • Rumble Inc. (NASDAQ: RUM) gained 11.4% to close at $12.99 amid the start of Russell Brand's show on the platform. It was also rumored Elon Musk may appear on the show next week.
  • Alpha Metallurgical Resources, Inc. (NYSE: AMR) jumped 11.3% to close at $138.60.
  • EQRx, Inc. (NASDAQ: EQRX) gained 11.1% to settle at $5.20.
  • Guardant Health, Inc. (NASDAQ: GH) jumped 10.7% to close at $54.89.
  • Chegg, Inc. (NYSE: CHGG) rose 10.6% to settle at $22.68.
  • HashiCorp, Inc. (NASDAQ: HCP) gained 10.5% to settle at $32.83.
  • Eve Holding, Inc. (NYSE: EVEX) jumped 10% to close at $11.02.
  • Netflix, Inc. (NASDAQ: NASDAQ:NFLX) gained 9.3% to close at $245.20 after Atlantic Equities upgraded the stock from Neutral to Overweight and raised its price target from $211 to $283.
  • Illumina, Inc. (NASDAQ: ILMN) jumped 7.7% to close at $201.29 after Evercore ISI Group upgraded the stock from In-Line to Outperform and announced a $250 price target.
  • Lilly and Company (NYSE: LLY) rose 7.5% to close at $334.38. Shares of companies with potential Alzheimer's treatments traded higher in sympathy with Biogen.
  • Hess Corporation (NYSE: NYSE:HES) gained 7.1% to close at $108.30.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.